STACIA H. GOLDEY, MD

LARGO, FL

Research Active
Ophthalmology NPI registered 21+ years 1 publication 1986 – 1986 NPI: 1033112156
Ophthalmology Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery
MiceCells, CulturedFlow CytometryCell SurvivalVibrio choleraeCell DivisionBromodeoxyuridineCatecholsChemical PhenomenaChemistryChromiumLeukemia L1210Oxazoles

Practice Location

148 13TH ST SW
LARGO, FL 33770-3127

Phone: (727) 581-8706

What does STACIA GOLDEY research?

Dr. Goldy's primary area of study involves the interaction between a compound called vibriobactin and cancer cells. Specifically, she examines how vibriobactin can inhibit the growth of L1210 cells, a type of cancer cell associated with lymphoma. By understanding how vibriobactin affects these cells, her work aims to pave the way for new treatment strategies that could improve outcomes for patients fighting cancer, particularly lymphoma.

Key findings

  • Vibriobactin inhibits the growth of L1210 cancer cells at a concentration of just 2 microM.
  • Once vibriobactin is removed, the previously affected L1210 cells can quickly re-enter a growth phase.
  • Understanding the effects of vibriobactin could help develop new cancer treatments specifically for lymphoma.

Frequently asked questions

Does Dr. Goldy study lymphoma?
Yes, Dr. Goldy focuses her research on lymphoma, specifically looking at how certain compounds affect the growth of cancer cells associated with this condition.
What treatments has Dr. Goldy researched?
She has researched the compound vibriobactin and its ability to inhibit the growth of specific cancer cells, which could lead to new treatment options for lymphoma.
Is Dr. Goldy's work relevant to cancer patients?
Yes, her research is directly relevant to cancer patients, particularly those with lymphoma, as it explores potential new treatment avenues.

Publications in plain English

Effects of the Vibrio cholerae siderophore vibriobactin on the growth characteristics of L1210 cells.

1986

Biochemical and biophysical research communications

Bergeron RJ, Braylan R, Goldey S, Ingeno M

Plain English
This study looked at how a compound called vibriobactin affects the growth of certain cancer cells. The researchers found that vibriobactin can stop these cells from growing at a concentration of just 2 microM, and when the drug is removed, the affected cells can rapidly enter a phase of growth. This is important because understanding how vibriobactin affects cell growth could lead to new treatments for cancers like lymphoma. Who this helps: Patients with specific types of cancer, particularly lymphoma.

PubMed

Frequent Co-Authors

R J Bergeron R Braylan M Ingeno

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.